| Starts: | Monday January 25, 2010 at 8:00am |
|---|---|
| Ends: | Wednesday January 27, 2010 at 5:00pm |
| Event Type: | Conference |
| Region: | Greater Philadelphia Area |
| Location: | Philadelphia, PA US |
| Price: | Standard price: $1,799, next discount expires 12/04/09 |
| Website: | http://www.anti-infectivesummit.com |
| Industry: | pharmaceuticals |
| Keywords: | Anti Infectives, Anti Bacterial, Anti Fungal, Anti Viral, Microbiology, Immunology, Clinical Trials, Antibiotics, Infection Discovery, Drug Resistance, Superbugs, Superdrugs, Pharmaceutical, Infectious Diseases, Medicinal Chemistry, Clinical Pharmacology |
| Intended For: | Head/VP/Director of: Microbiology, Immunology, Infectious Diseases, Medicinal Chemistry, Clinical Pharmacology, Drug Discovery, New Product Development, Scientific Affairs, Licensing, Antibiotics, Infection Discovery, Drug evaluation, Molecular Biotechnol |
| Organization: | IQPC |
Uncovering novel advances for increasing resistance in anti-infective drug development: The global anti-infective market is currently estimated at $66.5 billion, with anti-bacterial agents accounting for more than 50% of sales. Many biotechs and pharmaceutical companies are seeing developments in later stage clinical trials, specifically in anti-bacterial and anti-fungal, both of which are growing in demand. The threat of bacterial resistant strains of infectious diseases continually increases and creates a race to develop an effective resistant drug to combat these strains. The Anti-Infectives Summit will discuss effective lead generation approaches currently being used in anti-bacterial, anti-viral and anti-fungal drug discovery and address which biologics may play a role in anti-infective therapy.